APP and Alzheimer disease: NrCAM is a marker of ADAM10 activity and in case of its decreased activity, which may be monitored by decreased concentration of NrCAM, APP is less degraded and therefore more beta-amyloid accumulates, which is an important link in AD pathogenesis [22].